OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in Doxorubicin-based nano-drug delivery system in triple negative breast cancer
Weiwei Zeng, Yuning Luo, Dali Gan, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 17

Showing 17 citing articles:

Targeted Drug Delivery of Cancer Cell-derived Extracellular Vesicles Decorated with a VEGFR-binding Peptide
Young‐Min Kim, Hyeonseok Kim, Seong‐Cheol Park, et al.
Colloids and Surfaces B Biointerfaces (2025), pp. 114661-114661
Closed Access

Chitosan-grafted folic acid decorated one-dimensional GONS: A biocompatible drug cargo for targeted co-delivery of anticancer agents
Ankush D. Sontakke, Paras Gupta, S. K. Banerjee, et al.
International Journal of Biological Macromolecules (2024) Vol. 271, pp. 132621-132621
Closed Access | Times Cited: 4

Mechanistic insights into pachymic acid’s action on triple-negative breast Cancer through TOP2A targeting
Ming Liu, Li Zheng, Yang Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

Reducing toxicity and enhancing efficacy of doxorubicin by liposomal doxorubicin and aprepitant in breast cancer
Atefeh Ghahremanloo, Bahareh Erfani, Fereshteh Asgharzadeh, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

PYCR3 modulates mtDNA copy number to drive proliferation and doxorubicin resistance in triple-negative breast cancer
Feifei Zhuang, Shaoyan Huang, Lei Liu
The International Journal of Biochemistry & Cell Biology (2024) Vol. 171, pp. 106581-106581
Closed Access | Times Cited: 3

Recent Progress of Multifunctional Molecular Probes for Triple-Negative Breast Cancer Theranostics
Deyi Zhao, Zhe Li, Ding‐Kun Ji, et al.
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 803-803
Open Access | Times Cited: 3

Nanomaterials: leading immunogenic cell death-based cancer therapies
Changyu Ma, Zhe Cheng, Haotian Tan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3

New Transferrin Receptor-Targeted Peptide–Doxorubicin Conjugates: Synthesis and In Vitro Antitumor Activity
Jiale Yu, Xiaoxia Mao, Xue Yang, et al.
Molecules (2024) Vol. 29, Iss. 8, pp. 1758-1758
Open Access | Times Cited: 2

A Nanorobotics-Based Approach of Breast Cancer in the Nanotechnology Era
Anca-Narcisa Neagu, Taniya Jayaweera, Krishan Weraduwage, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4981-4981
Open Access | Times Cited: 2

Delivery of doxorubicin by Fe3O4 nanoparticles, reduces multidrug resistance gene expression in ovarian cancer cells
Roghiyeh Pashaei‐Asl, Soheila Motaali, Esmaeil Ebrahimie, et al.
Pathology - Research and Practice (2024) Vol. 263, pp. 155667-155667
Closed Access | Times Cited: 1

A Graphene-Based Lipid Modulation Nanoplatform for Synergetic Lipid Starvation/Chemo/Photothermal Therapy of Oral Squamous Cell Carcinoma
Ran Li, Yanwei Li, Zijian Song, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 11235-11255
Open Access

Antineoplastic effect of doxorubizen in vitro in continuous and primary human anaplastic thyroid cancer cells
Giusy Elia, Silvia Martina Ferrari, Iryna Tkachenko, et al.
Endocrine (2024)
Closed Access

Ethanolic Extract of Averrhoa carambola Leaf Has an Anticancer Activity on Triple-Negative Breast Cancer Cells: An In Vitro Study
Oscar F. Beas-Guzmán, Ariana Cabrera‐Licona, Gustavo A. Hernández‐Fuentes, et al.
Pharmaceutics (2024) Vol. 17, Iss. 1, pp. 2-2
Open Access

Polymeric Micelle-Based Nanogels as Emerging Drug Delivery Systems in Breast Cancer Treatment: Promises and Challenges
Mostafa Yazdan, Seyed Morteza Naghib, M. R. Mozafari
Current Drug Targets (2024) Vol. 25, Iss. 10, pp. 649-669
Closed Access

Page 1

Scroll to top